Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Black Diamond Therapeutics, Inc. market cap for the quarter ending 2026-07-30 was $98.25M, a 33.38% decline year-over-year.
Black Diamond Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $105.7M, a 25.08% decline year-over-year.
Black Diamond Therapeutics, Inc. market cap for the quarter ending 2026-05-01 was $148.41M, a 78.16% increase year-over-year.
Black Diamond Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $122.05M, a 38.93% increase year-over-year.
Black Diamond Therapeutics, Inc. market cap for fiscal 2026 was $98.25M.
Black Diamond Therapeutics, Inc. market cap for fiscal 2025 was $139.42M, a 15.01% increase from fiscal 2024.
Black Diamond Therapeutics, Inc. market cap for fiscal 2024 was $121.22M, a 16.47% decline from fiscal 2023.
Black Diamond Therapeutics, Inc. market cap for fiscal 2023 was $145.12M, a 121.29% increase from fiscal 2022.